249 related articles for article (PubMed ID: 7589072)
81. The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.
Saban DR; Cornelius J; Masli S; Schwartzkopff J; Doyle M; Chauhan SK; Peck AB; Grant MB
Mol Vis; 2008; 14():2435-42. PubMed ID: 19104677
[TBL] [Abstract][Full Text] [Related]
82. Induction of Contrasuppressor Cells and Loss of Immune Privilege Produced by Corneal Nerve Ablation.
Neelam S; Mellon J; Wilkerson A; Niederkorn JY
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4738-4747. PubMed ID: 30267096
[TBL] [Abstract][Full Text] [Related]
83. Skin tolerance is supported by the spleen.
Buettner M; Bornemann M; Bode U
Scand J Immunol; 2013 Apr; 77(4):238-45. PubMed ID: 23421583
[TBL] [Abstract][Full Text] [Related]
84. Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10.
Ashour HM; Niederkorn JY
J Immunol; 2006 Dec; 177(12):8331-7. PubMed ID: 17142729
[TBL] [Abstract][Full Text] [Related]
85. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation.
Sonoda KH; Sakamoto T; Qiao H; Hisatomi T; Oshima T; Tsutsumi-Miyahara C; Exley M; Balk SP; Taniguchi M; Ishibashi T
Immunology; 2005 Nov; 116(3):390-9. PubMed ID: 16236129
[TBL] [Abstract][Full Text] [Related]
86. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations.
Wilbanks GA; Streilein JW
Immunology; 1990 Nov; 71(3):383-9. PubMed ID: 1702748
[TBL] [Abstract][Full Text] [Related]
87. Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation.
He H; Yang P; Jiang L; Zhang J; Zhao C; Chen L; Lin X; Zhou H; Kijlstra A
BMC Immunol; 2008 Sep; 9():53. PubMed ID: 18816417
[TBL] [Abstract][Full Text] [Related]
88. A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.
Lei F; Zhang J; Zhang J; He H; Du Y; Yang P
Mol Vis; 2008 Feb; 14():327-33. PubMed ID: 18334954
[TBL] [Abstract][Full Text] [Related]
89. Immune regulation and the eye: a dangerous compromise.
Streilein JW
FASEB J; 1987 Sep; 1(3):199-208. PubMed ID: 2957263
[TBL] [Abstract][Full Text] [Related]
90. Type II collagen induces peripheral tolerance in BALB/c mice via the generation of CD8+ T regulatory cells.
Farooq SM; Ashour HM
PLoS One; 2012; 7(11):e48635. PubMed ID: 23133648
[TBL] [Abstract][Full Text] [Related]
91. Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation.
Jiang L; He H; Yang P; Lin X; Zhou H; Huang X; Kijlstra A
Graefes Arch Clin Exp Ophthalmol; 2009 Jan; 247(1):87-92. PubMed ID: 18797912
[TBL] [Abstract][Full Text] [Related]
92. [Expression of programmed death 1 and its ligands in iris-ciliary body from mice with anterior chamber-associated immune deviation].
Meng QL; Yang PZ; Li B; Zhou HY; Huang XK; Zhu LX
Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):558-62. PubMed ID: 19035251
[TBL] [Abstract][Full Text] [Related]
93. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen.
Streilein JW; Niederkorn JY
J Exp Med; 1981 May; 153(5):1058-67. PubMed ID: 6788883
[TBL] [Abstract][Full Text] [Related]
94. The induction of anterior chamber-associated immune deviation.
Niederkorn JY
Chem Immunol Allergy; 2007; 92():27-35. PubMed ID: 17264480
[TBL] [Abstract][Full Text] [Related]
95. Serum TABM produced during anterior chamber-associated immune deviation passively transfers suppression of delayed-type hypersensitivity to primed mice.
Wang Y; O'Rourke J; Cone RE
Int Immunol; 1997 Feb; 9(2):211-8. PubMed ID: 9040003
[TBL] [Abstract][Full Text] [Related]
96. Two different regulatory T cell populations that promote corneal allograft survival.
Cunnusamy K; Paunicka K; Reyes N; Yang W; Chen PW; Niederkorn JY
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6566-74. PubMed ID: 20702818
[TBL] [Abstract][Full Text] [Related]
97. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes.
Wilbanks GA; Streilein JW
Immunology; 1990 Dec; 71(4):566-72. PubMed ID: 2149124
[TBL] [Abstract][Full Text] [Related]
98. Alloantigen presentation to the anterior chamber of the eye subverts specific in vitro cell-mediated immune responses.
Whittum JA; Niederkorn JY; Streilein JW
Transplantation; 1982 Oct; 34(4):190-5. PubMed ID: 6183804
[TBL] [Abstract][Full Text] [Related]
99. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response.
D'Orazio TJ; Niederkorn JY
Eur J Immunol; 1998 May; 28(5):1544-53. PubMed ID: 9603459
[TBL] [Abstract][Full Text] [Related]
100. An intracameral injection of antigen induces in situ chemokines and cytokines required for the generation of circulating immunoregulatory monocytes.
Pais R; Bhowmick S; Chattopadhyay S; Lemire Y; Sharafieh R; Yadav R; O'Rourke J; Cone RE
PLoS One; 2012; 7(8):e43182. PubMed ID: 22912822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
